AAAAAA
Results:
1-23
|
Results: 23
Authors:
Speroff, L
Mazzaferri, EL
Citation: L. Speroff et El. Mazzaferri, Hormone replacement therapy: Clarifying the picture, HOSP PRACT, 36(5), 2001, pp. 37
Authors:
Speroff, L
Citation: L. Speroff, Postmenopausal hormone therapy and primary prevention of cardiovascular disease - Nurses' health study 20-year follow-up, MATURITAS, 38(3), 2001, pp. 221-224
Authors:
Pickar, JH
Yeh, IT
Wheeler, JE
Cunnane, MF
Speroff, L
Citation: Jh. Pickar et al., Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate, FERT STERIL, 76(1), 2001, pp. 25-31
Authors:
Speroff, L
Symons, J
Kempfert, N
Rowan, J
Citation: L. Speroff et al., The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt (R)) on the frequency and intensity of vasomotor symptoms, MENOPAUSE, 7(6), 2000, pp. 383-390
Authors:
Jensen, JT
Speroff, L
Citation: Jt. Jensen et L. Speroff, Health benefits of oral contraceptives, OB GYN CLIN, 27(4), 2000, pp. 705
Authors:
Speroff, L
Citation: L. Speroff, Postmenopausal hormone therapy and coronary heart disease: clinical implications of recent randomized trial results, MATURITAS, 35(2), 2000, pp. 91-97
Authors:
Speroff, L
Citation: L. Speroff, It's time to stop using the word 'replacement', MATURITAS, 34(1), 2000, pp. 1-3
Authors:
Symons, J
Kempfert, N
Speroff, L
Citation: J. Symons et al., Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations, OBSTET GYN, 96(3), 2000, pp. 366-372
Authors:
Speroff, L
Citation: L. Speroff, A clinician's response to the oral contraceptive thrombosis controversy, HUM REP UPD, 5(6), 1999, pp. 654-663
Authors:
Speroff, L
Citation: L. Speroff, Endocrinology of the climacteric - Preface, SEM REP END, 17(4), 1999, pp. 295-295
Authors:
Speroff, L
Citation: L. Speroff, From endometrial receptivity to implantation: A molecular perspective - Preface, SEM REP END, 17(3), 1999, pp. 195-195
Authors:
Speroff, L
Citation: L. Speroff, Diabetes and development - Preface, SEM REP END, 17(2), 1999, pp. 117-117
Authors:
Speroff, L
Citation: L. Speroff, Regulation of endometrial function - Preface, SEM REP END, 17(1), 1999, pp. 1-1
Authors:
Speroff, L
Citation: L. Speroff, Postmenopausal hormone therapy and the risk of breast cancer, MATURITAS, 32(3), 1999, pp. 123-129
Authors:
Speroff, L
Citation: L. Speroff, Women's healthcare in the 21st century, MATURITAS, 32(1), 1999, pp. 1-9
Authors:
Speroff, L
Citation: L. Speroff, Role of progesterone in normal breast physiology, J REPRO MED, 44(2), 1999, pp. 172-179
Authors:
Barbieri, RL
Speroff, L
Walker, AM
McPherson, K
Citation: Rl. Barbieri et al., The safety of third-generation oral contraceptives, J CLIN END, 84(6), 1999, pp. 1822-1823
Authors:
Speroff, L
Citation: L. Speroff, Modern low-dose oral contraceptives are very safe, J CLIN END, 84(6), 1999, pp. 1823-1825
Authors:
Speroff, L
Citation: L. Speroff, Free radicals in gynecology and obstetrics - Foreword, SEM REP END, 16(4), 1998, pp. 231-231
Authors:
Speroff, L
Citation: L. Speroff, Preimplantation embryo development - Foreword, SEM REP END, 16(3), 1998, pp. 173-173
Authors:
Speroff, L
Citation: L. Speroff, Androgens in menopause - Foreword, SEM REP END, 16(2), 1998, pp. 107-107
Authors:
Speroff, L
Citation: L. Speroff, Endocrinology of preeclampsia - Foreword, SEM REP END, 16(1), 1998, pp. 1-1
Authors:
Speroff, L
Citation: L. Speroff, The heart and estrogen/progestin replacement study (HERS), MATURITAS, 31(1), 1998, pp. 9-14
Risultati:
1-23
|